Plethico Pharmaceuticals (Delisted) share news and announcements

BSE: 532739

Last traded ₹9.05 on 13 Jun 2016

Delisted on 11 May 2018.

Plethico Pharmaceuticals shareholder meetings

42 filed, newest first.

  1. Jan 2016

  2. Dec 2015

  3. Nov 2014

    • 28 Nov · Meeting

      Register of Members & Share Transfer Books of the Company will remain closed from December 17, 2014 to December 19, 2014 (both days ....
    • 27 Nov · Meeting

      Register of Members & Share Transfer Books of the Company will remain closed from December 17, 2014 to December 19, 2014 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on December 26, 2014.
  4. Jun 2013

    • 18 Jun · Meeting

      Register of Members & Share Transfer Books of the Company will remain closed from June 25, 2013 to June 28, 2013 (both days inclusive) ....
  5. Apr 2013

  6. Mar 2013

  7. Jul 2012

  8. Jun 2012

  9. Sep 2011

  10. Aug 2011

    • 18 Aug · Meeting

      Register of Members & Share Transfer Books of the Company will remain closed from September 26, 2011 to September 28, 2011 (both days ....
    • 16 Aug · Meeting

      Board of Directors of the Company at their meeting held on August 12, 2011, inter-alia considered the following: (1) Fixing September 28, 2011 for holding the Annual General Meeting of the members of the Company for the accounting year ended December 31, 2010. (2) The Register of Members and Share Transfer Books would remain closed from September 26, 2011 to September 28, 2011 (both days inclusive) for the purpose of distribution of dividend to the members for the accounting year ended December 31, 2010.
  11. Jun 2011

    • 8 Jun · Meeting

      Board of Directors in their meeting held on June 03, 2011 had decided to defer the Annual General Meeting to a future date and given their consent to file application with the Registrar of Companies, Madhya Pradesh & Chhattisgarh for seeking extension of time for convening Annual General Meeting of the Company for the financial year ended on December 31, 2010 for a further period of 3 months. Further the Company has informed that Application was made to ROC for extension of AGM and the Registrar of Companies, Madhya Pradesh & Chhattisgarh, vide their letter dated June 06, 2011 had granted the Company extension of 3 (Three) months time for holding the Annual General Meeting for the financial year ended on December 31, 2010.
    • 7 Jun · Meeting

      With reference to earlier announcement dated June 03, 2011 informing that the Board of Directors of the Company at its meeting held on June 03, 2011, inter alia, had decided to defer the ....
    • 3 Jun · Meeting

      Members at the Extra Ordinary General Meeting (EGM) of the Company held on June 03, 2011, inter alia, have accorded to the following: ....
  12. May 2011

  13. Jan 2011

    • 10 Jan · Meeting

      Members at the Extra Ordinary General Meeting (EGM) of the Company held on January 10, 2011, inter alia, have approved the following ....
    • 10 Jan · Meeting

      An Extra-Ordinary General Meeting of the members of the Company held on January 10, 2011 and following decisions have been approved by the members of the Company: 1) Amendment in the Articles of Association of the Company for providing power to the Company and its Board of Directors in relation to the issuance of the warrants. 2) To offer, issue and allot 20,00,000 warrants at a price of Rs.400/- per warrant convertible into one equity share of Rs.10/- each fully paid up at price of Rs.400/- per share including premium of Rs.390 per share on preferential allotment basis.
  14. Dec 2010

  15. Jun 2010

    • 30 Jun · Meeting

      Members at the 17th Annual General Meeting (AGM) of the Company held on June 30, 2010, have accorded to the following: 1. Adoption ....
    • 4 Jun · Meeting

      Register of Members & Share Transfer Books of the Company will remain closed from June 28, 2010 to June 30, 2010 (both days inclusive) ....
    • 3 Jun · Meeting

      Board of Directors at their meeting held on June 02, 2010 considered various matters and following decision were taken: (1) The Annual General Meeting of the members of the Company for the accounting year ended on December 31, 2009 has been scheduled to be held on June 30, 2010.(2) That the Register of Members and Share Transfer Books will remain closed from June 28, 2010 to June 30, 2010 (both days Inclusive) for the purpose of distribution of dividend to the members for the accounting year ended on December 31, 2009.
  16. Apr 2010

  17. Jun 2009

    • 26 Jun · Meeting

      Annual General Meeting of the members of the Company held on June 26, 2009 and following decision have been taken: (1). Company has declared the dividend for the year 2008 of Rs. 2.50 per equity share i.e @ 25%. (2). Dr. G.N. Qazi arid Mr. Pramod Shrivastava are re-appointed as Director of the Company. (3). M/s. N. P. Gandhi & Co. has been appointed as Statutory Auditors of the Company. (4). Authority to Board of Directors u/s 372A of the Companies Act, 1956 for Investment in Tricon Holdings FZE, UAE.
  18. Mar 2009

    • 31 Mar · Meeting

      Board of Directors of the Company at their meeting held on March 31, 2009 considered the proposals and following decision were taken:- (1) The Board has recommended dividend @ 25 % i.e. Rs. 2.50 per equity share of the Company. (2) The Annual General Meeting of the members of the Company for the accounting year ended on December 31, 2008 is scheduled to be held on June 26, 2009. (3) The Register of Members and Share Transfer Books will remain closed from June 22, 2009 to June 26, 2009 (both days inclusive) for the purpose of distribution of dividend to the members for the accounting year ended on December 31, 2008.
    • 31 Mar · Meeting

      At the Extra-Ordinary General Meeting of the members of the Company held on March 31, 2009, the following decision have been approved by the members of the Company: (1) The issuance of equity shares and/or FCCB and/or GDR and/or other securities convertible into equity shares and/or such other equity-linked instruments to an extent of US$ 40 Million Indian Rupee equivalent. (2) Authority to Board of Directors to borrow in excess of paid-up capital and free reserve to an extent of Rs. 1200 Crores (Rupees One Thousand Two Hundred Crores only) at a time.
    • 12 Mar · Meeting

      Board of Directors of the Company at its meeting held on March 09, 2009 decided the following: [1] To borrow, subject to the approval of the Company in general meeting, to the extent of Rs.1200 crores, notwithstanding that the moneys to be borrowed together with the money's already borrowed by the Company (apart from temporary loans, if any, obtained from the Company's bankers in the ordinary course of business) will exceed the aggregate of the paid-up capital of the Company and its free reserves; [2] To consider, subject to the approval of the company in general meeting the issuance of equity shares and/or foreign currency convertible bonds ("FCCBs") and/or global depository receipts and/or other securities convertible into equity shares and/or such other equity-linked instruments to an extent of US$40 Million Indian Rupee equivalent, including, but not limited to, by way of a qualified institutional placement; [3] To look into and evaluate options for managing the liabilities of the Company through various initiatives, such as amending the terms and conditions of the outstanding FCCBS issued by the Company, including, but not limited to, tenor, interest rate, yield to maturity, etc., as well as other methods of extinguishing or restructuring the FCCBs, including but not limited to, buy- back/ early redemption of the FCCBs, as may be permitted by applicable law. The Company has appointed Jefferies International Limited to advise the Company in relation to the above. The decisions of the board at serial nos. 1 and 2 above are subject, inter alia, to the approval by the shareholders of the Company and the Company will, in this regard, calling an extraordinary general meeting of all its shareholders. The Extra-ordinary General Meeting of the Company is proposed to be held on March 31, 2009.
  19. Jun 2008

    • 27 Jun · Meeting

      Decisions taken at the Annual General Meeting of the members of the Company held on June 27, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  20. May 2008

    • 27 May · Meeting

      Board of Directors at their meeting held on May 27, 2008 considered the proposals and following decision were taken: (1) That the Register of Members and Share Transfer Books will remains closed from June 24, 2008 to June 27, 2008 (both days inclusive) for the purpose of distribution of dividend to the members for the accounting year ended on December 31, 2007. (2) That Annual General Meeting of the members of the Company for the accounting year ended on December 31, 2007 scheduled to be held on June 27, 2008.
  21. Mar 2007

    • 30 Mar · Meeting

      The 14th Annual General Meeting of the members of the Company held on Friday the 30th day of March 2007 at the Registered office of the Company and following decisions have been taken :- (1) Company has declared the dividend for the year 2005-06 of Rs. 2.50 per equity share i.e. @25%. (2) Mr. Ashok Sodhani, Dr. G.N. Qazi, Mr. Pramod K. Shrivastava and Mr. Abhay Suhane are appointed as Director of the Company. (3) The Board of Directors of the Company is authorized to decide sitting fees for attending the board meetings /compensation payable for professional services rendered by the Non-Executive Independent Directors to the Company. (4) Revision in the remuneration and benefits payable to Shri Shashikant Patel Chairman cum managing Director of the Company effective from 1st day of January, 2007 for the remaining part of his tenure till 31st March, 2008. (5) Revision in the remuneration and benefits payable to Shri Chirag Patel, Whole-Time Director & Chief Executive Officer of the Company effective from 1st day of January, 2007 for the remaining part of his tenure till 31st March, 2008. (6) Board of Directors is authorized to finalize the proposals related to acquisition of Retail Pharmacy chain and/or Manufacturing Unit and/or OTC Brand and/or Marketing Firms etc. in the US markets requiring total investment no exceeding Rs. 400 Crores by fulfilling all the formalities as required to be complied with under different Acts as are in force. (7) Unutilized portion of IPO proceeds up to maximum extent of Rs. 35 Crores be utilized by the company for company's proposals related to acquisition of Retail Pharmacy Chain and/or Manufacturing Unit and/or OTC Brand and/or Marketing Firms etc. in the US Markets. (8) Company is authorized to issue Foreign Convertible Currency Bond (FCCB) not exceeding US$ 75 million (approx. Rs. 330 crores), subject to however compliance of applicable rules, regulations and guidelines as issued by the Reserve Bank of India or all other regulatory authorities from time to time as well as compliance of applicable provisions of the Foreign Exchange Management Act, 1999. It will be used to finance the proposal related to acquisition of Retail Pharmacy Chain and/or Manufacturing Unit and/or OTC Band and/or Marketing Firms etc. in the US Markets.
  22. Feb 2007

    • 26 Feb · Meeting

      The Board of Directors at their meeting held on Monday the 26th day of February, 2007 considered the proposals and following decision were taken:- 1) that the Register of Members and Share Transfer Books will remain closed from 27.03.2007 to 30.03.2007 (both days inclusive) for the purpose of distribution of dividend to the members for the year ended on 30.09.2006; 2) that the 14th Annual General Meeting of the members of the Company for the year ended on 30.09.2006 scheduled to be held on Friday the 30th day of March 2007 at the Registered Office of the company at 9.30 A.M; 3) that subject to the approval of the members in the forthcoming Annual General Meeting, Foreign Currency Convertible Bond (FCCB) not exceeding US$ 75 Millions be issued to finance Company's project related to acquisition of Retail Pharmacy Chain and/or Manufacturing Unit and/or OTC Brand and/or Marketing Firms etc. in US Market; and 4) that subject to the approval of the members in the forthcoming Annual General Meeting, the unutilized portion of IPO proceeds to the extent of Rs. 35.00 Crores be utilized by the Company for the purpose of acquiring Retail Pharmacy Chain and/or Manufacturing Unit and/or OTC Brand and/or Marketing Firms etc. in US Market and the projects specified in the Prospectus dated 19.04.2006 not as yet implemented are now to be completed out of internal accruals and/or bank finance and/or any other finance option then available. This modification is recommended in order to maximize return on investment. Accordingly the Board has recommended that out of total IPO proceeds of Rs. 110 Crores, Rs. 75.00 Crores are to be utilized for different projects specified in the prospectus dated 19.04.2006 and related IPO expenses and balance of Rs. 35 Crores for the acquisition of Retail Pharmacy Chain and/or Manufacturing Unit and/or OTC Brand and/or Marketing Firms etc. in US Market